Theravance Biopharma(TBPH) - 2025 Q3 - Earnings Call Transcript

Theravance Biopharma (NasdaqGM:TBPH) Q3 2025 Earnings Call November 10, 2025 05:00 PM ET Company ParticipantsRhonda Farnum - Chief Business OfficerJulian Harrison - MDRick Winningham - CEOAine Miller - Head of DevelopmentDouglas Tsao - MD Equity ResearchEllen Horste - Equity Research AssociateAziz Sawaf - CFOOperatorLadies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma Q3 2025 conference call. During the presentation, all participants will be in a listen-only mode. A ...